Differences in provider approach to initiating and titrating guideline directed medical therapy in heart failure with reduced ejection fraction
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Differences in provider approach to initiating and titrating guideline directed medical therapy in heart failure with reduced ejection fraction ; volume:24 ; number:1 ; day:11 ; month:5 ; year:2024 ; pages:1-7 ; date:12.2024
BMC cardiovascular disorders ; 24, Heft 1 (11.5.2024), 1-7, 12.2024
- Urheber
-
Cordwin, David J.
Guidi, Jessica
Alhashimi, Lana
Hummel, Scott L.
Koelling, Todd M.
Dorsch, Michael P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-024-03911-1
- URN
-
urn:nbn:de:101:1-2407221024376.170156352069
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cordwin, David J.
- Guidi, Jessica
- Alhashimi, Lana
- Hummel, Scott L.
- Koelling, Todd M.
- Dorsch, Michael P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Right ventricular ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Dynamic trajectories of left ventricular ejection fraction in heart failure with improved ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Vericiguat for Heart Failure with Reduced Ejection Fraction
Biomarkers in heart failure with preserved ejection fraction
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
The effect of provider- and workflow-focused strategies for guideline implementation on provider acceptance
Animal models of heart failure with preserved ejection fraction
Right ventricular ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Dynamic trajectories of left ventricular ejection fraction in heart failure with improved ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Vericiguat for Heart Failure with Reduced Ejection Fraction
Biomarkers in heart failure with preserved ejection fraction
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
The effect of provider- and workflow-focused strategies for guideline implementation on provider acceptance
Animal models of heart failure with preserved ejection fraction
Right ventricular ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Dynamic trajectories of left ventricular ejection fraction in heart failure with improved ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Vericiguat for Heart Failure with Reduced Ejection Fraction
Biomarkers in heart failure with preserved ejection fraction
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
The effect of provider- and workflow-focused strategies for guideline implementation on provider acceptance